Bracco, Lucía
Pinto-Carral, Arrate
Hillaert, Linda
Mourey, France
Article History
Received: 30 May 2023
Accepted: 22 September 2023
First Online: 24 October 2023
Change Date: 8 May 2026
Change Type: Update
Change Details: The original online version of this article was revised: the authors would like to correct the Ethics approval and consent to participate section.
Change Date: 8 May 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12877-026-07538-z
Declarations
:
: The study was conducted following the Declaration of Helsinki, was approved by the Research Ethics Committee of the University of Burgundy (CERUBFC-2022–09-29–031) and was registered at ClinicalTrials.gov (ID: NCT05744011). Each person likely to take part in this research was informed and a summary document on the main characteristics of the study was given during the inclusion visit. The written informed consent statement was given for immediate signature or after a reflection period. In case of doubt about the patient's ability to give consent, caregivers and the healthcare team were asked to help measure the expression of the person's autonomy and presumed wishes. In the case of persons under legal protection, the magistrate and the competent judge were informed, and authorization was requested.The authors wish to clarify that although the study received approval from the University Research Ethics Committee (CER), under French regulatory classification the research should have been submitted to a Comité de Protection des Personnes (CPP). This administrative oversight does not affect participant consent, safety, or the scientific validity of the study.
: Not applicable.
: The authors declare no competing interests.